Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Fabian

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Breast Cancer Research : BCR|March 16, 2001
Breast cancer chemoprevention: beyond tamoxifenC J Fabian
International Journal of Clinical Practice|September 26, 2007
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancerC J Fabian
The Breast Journal|March 22, 2002
Chemoprevention for high-risk women: tamoxifen and beyondC J Fabian, B F Kimler
Annals of the New York Academy of Sciences|January 25, 2002
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer preventionC J Fabian, B F Kimler
Journal of the National Cancer Institute|December 6, 2001
Breast cancer risk prediction: should nipple aspiration fluid cytology be incorporated into clinical practice?C J Fabian, B F Kimler
Journal of Cellular Biochemistry. Supplement|April 13, 2000
Breast cancer chemoprevention trials using the fine-needle aspiration modelB F Kimler, C J Fabian, D D Wallace
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Identification of a chemoprevention cohort from a population of women at high risk for breast cancerC J Fabian, S Kamel, C Zalles, et al.
Investigational New Drugs|January 1, 1983
Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot studyC D Haas, C J Fabian, R L Stephens, et al.
Cancer Treatment Reports|July 1, 1982
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group StudyC J Fabian, L H Baker, C B Vaughn, et al.
Endocrine-Related Cancer|June 11, 2005
Breast-tissue sampling for risk assessment and preventionC J Fabian, B F Kimler, M S Mayo, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Breast Cancer Research : BCR|March 16, 2001
Breast cancer chemoprevention: beyond tamoxifenC J Fabian
International Journal of Clinical Practice|September 26, 2007
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancerC J Fabian
The Breast Journal|March 22, 2002
Chemoprevention for high-risk women: tamoxifen and beyondC J Fabian, B F Kimler
Annals of the New York Academy of Sciences|January 25, 2002
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer preventionC J Fabian, B F Kimler
Journal of the National Cancer Institute|December 6, 2001
Breast cancer risk prediction: should nipple aspiration fluid cytology be incorporated into clinical practice?C J Fabian, B F Kimler
Journal of Cellular Biochemistry. Supplement|April 13, 2000
Breast cancer chemoprevention trials using the fine-needle aspiration modelB F Kimler, C J Fabian, D D Wallace
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Identification of a chemoprevention cohort from a population of women at high risk for breast cancerC J Fabian, S Kamel, C Zalles, et al.
Investigational New Drugs|January 1, 1983
Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot studyC D Haas, C J Fabian, R L Stephens, et al.
Cancer Treatment Reports|July 1, 1982
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group StudyC J Fabian, L H Baker, C B Vaughn, et al.
Endocrine-Related Cancer|June 11, 2005
Breast-tissue sampling for risk assessment and preventionC J Fabian, B F Kimler, M S Mayo, et al.
Pageof 4